Myriad Genetic Laboratories, Inc.
16 clinical trials · Sponsor
◉ Watch Myriad Genetic Laboratories, Inc.
| Record | Firm | Date |
|---|---|---|
| Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing (NCT04404894) | Myriad Genetic Laboratories, Inc. | 2020-04-30 |
| EndoPredict® Extended Endocrine Trial (EXET) (NCT04016935) | Myriad Genetic Laboratories, Inc. | 2019-07-02 |
| A Registry for Hereditary Cancer Risk Assessment and Genetic Testing (NCT04015102) | Myriad Genetic Laboratories, Inc. | 2019-03-06 |
| Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing (NCT03511235) | Myriad Genetic Laboratories, Inc. | 2018-03-12 |
| Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer (NCT03290508) | Myriad Genetic Laboratories, Inc. | 2017-09-14 |
Track Myriad Genetic Laboratories, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.